Trifluridine and Tipiracil Hydrochloride Combination-Induced Interstitial Pneumonia: A Case Report

Shun Nakazawa, Motoyasu Kato, Yuriko Terayama, Naho Sakamoto Matubara, Yoshihiko Sato, Ryoko Murashima, Daisuke Hayakawa, Shouichi Okamoto, Kazuhisa Takahashi Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, JapanCorrespondence: Shun Nakazawa, De...

Full description

Bibliographic Details
Main Authors: Nakazawa S, Kato M, Terayama Y, Sakamoto Matubara N, Sato Y, Murashima R, Hayakawa D, Okamoto S, Takahashi K
Format: Article
Language:English
Published: Dove Medical Press 2024-02-01
Series:International Medical Case Reports Journal
Subjects:
Online Access:https://www.dovepress.com/trifluridine-and-tipiracil-hydrochloride-combination-induced-interstit-peer-reviewed-fulltext-article-IMCRJ
_version_ 1827355447394304000
author Nakazawa S
Kato M
Terayama Y
Sakamoto Matubara N
Sato Y
Murashima R
Hayakawa D
Okamoto S
Takahashi K
author_facet Nakazawa S
Kato M
Terayama Y
Sakamoto Matubara N
Sato Y
Murashima R
Hayakawa D
Okamoto S
Takahashi K
author_sort Nakazawa S
collection DOAJ
description Shun Nakazawa, Motoyasu Kato, Yuriko Terayama, Naho Sakamoto Matubara, Yoshihiko Sato, Ryoko Murashima, Daisuke Hayakawa, Shouichi Okamoto, Kazuhisa Takahashi Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, JapanCorrespondence: Shun Nakazawa, Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, 3-1-3 Hongo, Bunkyo-ku, Tokyo, 113-8431, Japan, Tel +81 3-3813-3111, Fax +81 3-3812-7560, Email shu-nakazawa@juntendo.ac.jpAbstract: We report a case of a 62-year-old male who was diagnosed with advanced rectal cancer. The attending gastro-enterologist initiated chemotherapy using capecitabine plus oxaliplatin and bevacizumab; however, this treatment regimen was discontinued, as the patient developed a skin rash. Once the skin rash improved, chemotherapy was re-initiated using a combination of trifluridine and tipiracil hydrochloride (TAS-102). The patient developed high fever and dyspnea 2 months after initiation of TAS-102. Chest high-resolution computed tomography showed bilateral diffuse ground glass opacities in all lung lobes with traction bronchiectasis. At this time, the gastro-enterologist consulted our department. The patient was put on non-invasive positive pressure ventilation due to worsening respiratory symptoms. The patient was suspected to develop TAS-102-induced interstitial pneumonia based on positive TAS-102 drug-induced lymphocyte stimulation test. The patient’s respiratory symptoms and radiological findings improved after corticosteroid treatment. The corticosteroid dose was gradually decreased by 5 mg. Thereafter, chemotherapy was re-initiated using different anti-cancer agents.Keywords: TAS-102, colorectal cancer, DAD, corticosteroid
first_indexed 2024-03-08T04:12:04Z
format Article
id doaj.art-e68b1fb49c9d47d38471543db38593f9
institution Directory Open Access Journal
issn 1179-142X
language English
last_indexed 2024-03-08T04:12:04Z
publishDate 2024-02-01
publisher Dove Medical Press
record_format Article
series International Medical Case Reports Journal
spelling doaj.art-e68b1fb49c9d47d38471543db38593f92024-02-08T18:28:25ZengDove Medical PressInternational Medical Case Reports Journal1179-142X2024-02-01Volume 1710110490287Trifluridine and Tipiracil Hydrochloride Combination-Induced Interstitial Pneumonia: A Case ReportNakazawa SKato MTerayama YSakamoto Matubara NSato YMurashima RHayakawa DOkamoto STakahashi KShun Nakazawa, Motoyasu Kato, Yuriko Terayama, Naho Sakamoto Matubara, Yoshihiko Sato, Ryoko Murashima, Daisuke Hayakawa, Shouichi Okamoto, Kazuhisa Takahashi Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, JapanCorrespondence: Shun Nakazawa, Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, 3-1-3 Hongo, Bunkyo-ku, Tokyo, 113-8431, Japan, Tel +81 3-3813-3111, Fax +81 3-3812-7560, Email shu-nakazawa@juntendo.ac.jpAbstract: We report a case of a 62-year-old male who was diagnosed with advanced rectal cancer. The attending gastro-enterologist initiated chemotherapy using capecitabine plus oxaliplatin and bevacizumab; however, this treatment regimen was discontinued, as the patient developed a skin rash. Once the skin rash improved, chemotherapy was re-initiated using a combination of trifluridine and tipiracil hydrochloride (TAS-102). The patient developed high fever and dyspnea 2 months after initiation of TAS-102. Chest high-resolution computed tomography showed bilateral diffuse ground glass opacities in all lung lobes with traction bronchiectasis. At this time, the gastro-enterologist consulted our department. The patient was put on non-invasive positive pressure ventilation due to worsening respiratory symptoms. The patient was suspected to develop TAS-102-induced interstitial pneumonia based on positive TAS-102 drug-induced lymphocyte stimulation test. The patient’s respiratory symptoms and radiological findings improved after corticosteroid treatment. The corticosteroid dose was gradually decreased by 5 mg. Thereafter, chemotherapy was re-initiated using different anti-cancer agents.Keywords: TAS-102, colorectal cancer, DAD, corticosteroidhttps://www.dovepress.com/trifluridine-and-tipiracil-hydrochloride-combination-induced-interstit-peer-reviewed-fulltext-article-IMCRJtas-102colorectal cancerdadcorticosteroid
spellingShingle Nakazawa S
Kato M
Terayama Y
Sakamoto Matubara N
Sato Y
Murashima R
Hayakawa D
Okamoto S
Takahashi K
Trifluridine and Tipiracil Hydrochloride Combination-Induced Interstitial Pneumonia: A Case Report
International Medical Case Reports Journal
tas-102
colorectal cancer
dad
corticosteroid
title Trifluridine and Tipiracil Hydrochloride Combination-Induced Interstitial Pneumonia: A Case Report
title_full Trifluridine and Tipiracil Hydrochloride Combination-Induced Interstitial Pneumonia: A Case Report
title_fullStr Trifluridine and Tipiracil Hydrochloride Combination-Induced Interstitial Pneumonia: A Case Report
title_full_unstemmed Trifluridine and Tipiracil Hydrochloride Combination-Induced Interstitial Pneumonia: A Case Report
title_short Trifluridine and Tipiracil Hydrochloride Combination-Induced Interstitial Pneumonia: A Case Report
title_sort trifluridine and tipiracil hydrochloride combination induced interstitial pneumonia a case report
topic tas-102
colorectal cancer
dad
corticosteroid
url https://www.dovepress.com/trifluridine-and-tipiracil-hydrochloride-combination-induced-interstit-peer-reviewed-fulltext-article-IMCRJ
work_keys_str_mv AT nakazawas trifluridineandtipiracilhydrochloridecombinationinducedinterstitialpneumoniaacasereport
AT katom trifluridineandtipiracilhydrochloridecombinationinducedinterstitialpneumoniaacasereport
AT terayamay trifluridineandtipiracilhydrochloridecombinationinducedinterstitialpneumoniaacasereport
AT sakamotomatubaran trifluridineandtipiracilhydrochloridecombinationinducedinterstitialpneumoniaacasereport
AT satoy trifluridineandtipiracilhydrochloridecombinationinducedinterstitialpneumoniaacasereport
AT murashimar trifluridineandtipiracilhydrochloridecombinationinducedinterstitialpneumoniaacasereport
AT hayakawad trifluridineandtipiracilhydrochloridecombinationinducedinterstitialpneumoniaacasereport
AT okamotos trifluridineandtipiracilhydrochloridecombinationinducedinterstitialpneumoniaacasereport
AT takahashik trifluridineandtipiracilhydrochloridecombinationinducedinterstitialpneumoniaacasereport